Actively Recruiting
The Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform Program (SDS-GPS Program)
Led by Shwachman-Diamond Syndrome Alliance Inc · Updated on 2025-05-31
8000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program (SDS-GPS) provides a secure online platform for patients and families worldwide to share their experiences living with Shwachman-Diamond Syndrome (SDS) and related conditions. The program aims to deepen understanding of SDS, enhance patient lives, and speed up the development of new therapies and cures by gathering patient-reported data. SDS-GPS was created with input from patients, families, advocates, researchers, and clinicians to build a supportive global community that drives research forward. Participants create a free account to enter their information and complete surveys covering topics such as demographics, medical history, treatments, disease progression, care access, and quality of life. These surveys can be completed anytime from home and saved for later. The platform supports multiple languages and allows participants to track their medical appointments, medications, and symptoms. The program collects de-identified data to prioritize research, share knowledge, and connect participants with relevant clinical trials and registries. Throughout the program, participants provide ongoing information about symptoms, genetics, quality of life, and disease burden at baseline and at regular intervals such as every 12 months or multiple times per year. This long-term observational approach helps researchers understand patient needs and outcomes. Participation involves no clinic visits or virtual appointments, and privacy and security are maintained at the highest standards. The program offers early access to new research opportunities and supports participants in sharing information with their care teams as they choose.
CONDITIONS
Brief Title
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of any age with a confirmed diagnosis of Shwachman-Diamond Syndrome (genetic or clinical).
- Patients diagnosed with SDS-like syndromes due to mutations such as DNAJC21 or SRP54.
- Patients with other heritable blood disorders or congenital neutropenias like RUNX1-FPD or ELANE neutropenia.
- Caregivers, parents, and close relatives of patients with the above conditions, including those of deceased patients.
You will not qualify if you...
- Individuals who do not meet the above inclusion criteria.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (online)
Duration - Up to several years throughout study completion
Participants share their experiences and health information through online surveys to help researchers understand Shwachman-Diamond Syndrome and related conditions.
Surveys completed 2 to 4 times per year and annually for symptom and burden updates
Trial Site Locations
Total: 1 location
1
Shwachman-Diamond Syndrome Alliance Inc.
Woburn, Massachusetts, United States, 01888
Actively Recruiting
Research Team
E
Eszter Hars, Ph.D.
S
SDS-GPS Program Team
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here